US Stock MarketDetailed Quotes

ALPMY Astellas Pharma (ADR)

Watchlist
  • 9.890
  • +0.060+0.61%
15min DelayClose Mar 14 16:00 ET
17.70BMarket Cap-45.58P/E (TTM)

Astellas Pharma (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
22.63%517.41B
26.17%473.12B
5.60%1.6T
17.04%414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
16.58%354.25B
18.07%402.18B
Operating revenue
22.63%517.41B
26.17%473.12B
5.60%1.6T
17.04%414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
16.58%354.25B
18.07%402.18B
Cost of revenue
29.81%98.52B
32.18%91.14B
1.43%292.49B
17.58%73.23B
1.98%75.9B
18.52%74.41B
-22.42%68.95B
13.97%288.35B
5.71%62.28B
7.30%74.42B
Gross profit
21.05%418.89B
24.82%381.99B
6.58%1.31T
16.92%341.37B
5.58%346.04B
0.04%317.74B
4.48%306.04B
17.94%1.23T
19.19%291.97B
20.82%327.76B
Operating expense
62.94%533.09B
28.04%334.17B
17.61%1.29T
13.86%387.27B
23.00%327.17B
38.16%320.95B
0.27%260.99B
20.45%1.1T
32.24%340.12B
22.06%266B
Selling and administrative expenses
12.94%225.31B
23.01%206.88B
17.43%740.11B
21.25%193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
11.85%159.3B
19.94%163.02B
-General and administrative expense
12.94%225.31B
23.01%206.88B
17.43%740.11B
21.25%193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
11.85%159.3B
19.94%163.02B
Research and development costs
6.33%79.09B
34.41%86.82B
6.54%294.19B
11.10%77.85B
11.23%74.39B
18.70%77.36B
-12.72%64.59B
12.24%276.13B
2.51%70.08B
14.14%66.88B
-Depreciation and amortization
7.80%34.97B
285.88%34.99B
157.10%98.82B
252.48%32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
15.26%9.26B
17.02%9.21B
Other operating expenses
727.25%193.67B
-54.99%10.38B
6.54%167.81B
-18.29%83.84B
-16.34%23.41B
1,106.04%42.94B
-40.00%23.06B
51.00%157.52B
107.59%102.61B
50.26%27.98B
Operating profit
-705.28%-114.21B
6.13%47.82B
-85.60%18.95B
4.67%-45.9B
-69.45%18.87B
-103.77%-3.22B
38.09%45.06B
0.45%131.56B
-293.17%-48.14B
15.77%61.76B
Net non-operating interest income expense
-31.33%-2.17B
-115.34%-162M
17.79%-550M
-116.67%-62M
-1.23%-1.65B
-94.90%105M
171.89%1.06B
-155.75%-669M
-88.26%372M
-84.18%-1.63B
Non-operating interest income
74.58%2.06B
14.75%4.33B
41.25%11.46B
68.74%4.12B
0.60%1.18B
-33.41%2.37B
307.34%3.78B
31.89%8.11B
-36.40%2.44B
181.29%1.17B
Non-operating interest expense
49.36%4.23B
65.26%4.5B
36.75%12.01B
102.03%4.19B
0.96%2.83B
50.46%2.27B
13.52%2.72B
77.39%8.78B
206.96%2.07B
115.28%2.8B
Other net income (expense)
Special income (charges)
-73.58%84M
1,583.33%909M
4,491.98%9.74B
--0
783.33%318M
468,100.00%9.36B
-68.24%54M
-99.13%212M
-96.15%4M
-99.85%36M
-Less:Other special charges
73.58%-84M
-1,583.33%-909M
-4,491.98%-9.74B
--0
-783.33%-318M
-468,100.00%-9.36B
68.24%-54M
99.13%-212M
96.15%-4M
99.85%-36M
Income before tax
-783.64%-118.36B
7.78%50.5B
-81.14%24.97B
-1.64%-48.66B
-71.03%17.31B
-94.00%5.33B
47.89%46.85B
-15.63%132.36B
-355.28%-47.88B
-23.70%59.76B
Income tax
-839.25%-20.7B
-6.04%12.89B
-76.45%7.92B
-778.08%-15.38B
-75.34%2.8B
-60.49%6.79B
99.81%13.72B
2.58%33.65B
16.89%-1.75B
-34.87%11.35B
Net income
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
Net income continuous Operations
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.58%-46.13B
-20.50%48.41B
Minority interest income
Net income attributable to the parent company
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
Basic earnings per share
-774.29%-54.55
13.76%21
-82.47%9.51
26.36%-18.55
-69.54%8.09
-102.06%-0.81
35.84%18.46
-19.14%54.24
-468.62%-25.19
-19.17%26.56
Diluted earnings per share
-776.80%-54.55
13.68%20.94
-82.49%9.47
26.71%-18.55
-69.64%8.06
-102.06%-0.81
35.54%18.42
-19.33%54.09
-471.33%-25.31
-19.15%26.55
Dividend per share
0
0
14.23%69.2531
17.75%33.9272
0
11.04%35.3258
0
25.58%60.6264
22.09%28.8124
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 22.63%517.41B26.17%473.12B5.60%1.6T17.04%414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T16.58%354.25B18.07%402.18B
Operating revenue 22.63%517.41B26.17%473.12B5.60%1.6T17.04%414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T16.58%354.25B18.07%402.18B
Cost of revenue 29.81%98.52B32.18%91.14B1.43%292.49B17.58%73.23B1.98%75.9B18.52%74.41B-22.42%68.95B13.97%288.35B5.71%62.28B7.30%74.42B
Gross profit 21.05%418.89B24.82%381.99B6.58%1.31T16.92%341.37B5.58%346.04B0.04%317.74B4.48%306.04B17.94%1.23T19.19%291.97B20.82%327.76B
Operating expense 62.94%533.09B28.04%334.17B17.61%1.29T13.86%387.27B23.00%327.17B38.16%320.95B0.27%260.99B20.45%1.1T32.24%340.12B22.06%266B
Selling and administrative expenses 12.94%225.31B23.01%206.88B17.43%740.11B21.25%193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B11.85%159.3B19.94%163.02B
-General and administrative expense 12.94%225.31B23.01%206.88B17.43%740.11B21.25%193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B11.85%159.3B19.94%163.02B
Research and development costs 6.33%79.09B34.41%86.82B6.54%294.19B11.10%77.85B11.23%74.39B18.70%77.36B-12.72%64.59B12.24%276.13B2.51%70.08B14.14%66.88B
-Depreciation and amortization 7.80%34.97B285.88%34.99B157.10%98.82B252.48%32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B15.26%9.26B17.02%9.21B
Other operating expenses 727.25%193.67B-54.99%10.38B6.54%167.81B-18.29%83.84B-16.34%23.41B1,106.04%42.94B-40.00%23.06B51.00%157.52B107.59%102.61B50.26%27.98B
Operating profit -705.28%-114.21B6.13%47.82B-85.60%18.95B4.67%-45.9B-69.45%18.87B-103.77%-3.22B38.09%45.06B0.45%131.56B-293.17%-48.14B15.77%61.76B
Net non-operating interest income expense -31.33%-2.17B-115.34%-162M17.79%-550M-116.67%-62M-1.23%-1.65B-94.90%105M171.89%1.06B-155.75%-669M-88.26%372M-84.18%-1.63B
Non-operating interest income 74.58%2.06B14.75%4.33B41.25%11.46B68.74%4.12B0.60%1.18B-33.41%2.37B307.34%3.78B31.89%8.11B-36.40%2.44B181.29%1.17B
Non-operating interest expense 49.36%4.23B65.26%4.5B36.75%12.01B102.03%4.19B0.96%2.83B50.46%2.27B13.52%2.72B77.39%8.78B206.96%2.07B115.28%2.8B
Other net income (expense)
Special income (charges) -73.58%84M1,583.33%909M4,491.98%9.74B--0783.33%318M468,100.00%9.36B-68.24%54M-99.13%212M-96.15%4M-99.85%36M
-Less:Other special charges 73.58%-84M-1,583.33%-909M-4,491.98%-9.74B--0-783.33%-318M-468,100.00%-9.36B68.24%-54M99.13%-212M96.15%-4M99.85%-36M
Income before tax -783.64%-118.36B7.78%50.5B-81.14%24.97B-1.64%-48.66B-71.03%17.31B-94.00%5.33B47.89%46.85B-15.63%132.36B-355.28%-47.88B-23.70%59.76B
Income tax -839.25%-20.7B-6.04%12.89B-76.45%7.92B-778.08%-15.38B-75.34%2.8B-60.49%6.79B99.81%13.72B2.58%33.65B16.89%-1.75B-34.87%11.35B
Net income -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B
Net income continuous Operations -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.58%-46.13B-20.50%48.41B
Minority interest income
Net income attributable to the parent company -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B
Basic earnings per share -774.29%-54.5513.76%21-82.47%9.5126.36%-18.55-69.54%8.09-102.06%-0.8135.84%18.46-19.14%54.24-468.62%-25.19-19.17%26.56
Diluted earnings per share -776.80%-54.5513.68%20.94-82.49%9.4726.71%-18.55-69.64%8.06-102.06%-0.8135.54%18.42-19.33%54.09-471.33%-25.31-19.15%26.55
Dividend per share 0014.23%69.253117.75%33.9272011.04%35.3258025.58%60.626422.09%28.81240
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
297.490
MARA Holdings
MARA
13.180
Petroleo Brasileiro SA Petrobras
PBR
13.430
4
Adobe
ADBE
394.740
5
Vale SA
VALE
9.810
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.